Canary Foundation is a non-profit dedicated to the goal of identifying cancer early through a simple blood test and then isolating it with imaging. Our collaborative research programs span multiple disciplines and institutions.
VisionA world of simple tests that identify and isolate cancer at its earliest most curable stage. |
MissionDeliver early detection tests for solid tumor cancers by 2015. |
StrategyStimulate investment in the cancer diagnostics industry by demonstrating the first set of efficient, cost-effective early detection tests. |
Abbott, a company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, submits its ARCHITECT HE4 assay for approval. The assay uses a simple blood test to help in monitoring for the recurrence or progression of epithelial ovarian cancer. If approved, this important immunoassay would be the first automated HE4 test available in the United States. More
ABC-7 KGO Television of San Francisco profiles Canary Foundation and the Canary Center at Stanford: "Spotting cancer sooner than ever before" can be viewed here.
First Canary Foundation Researcher Awarded SPORE in Ovarian Cancer Research: Canary Foundation announces its first researcher, Nicole Urban, Sc.D., and collaborators are awarded 5 years of renewed funding from the National Institutes of Health (NIH) for the Pacific Ovarian Cancer Research Consortium (POCRC) Specialized Programs of Research Excellence (SPORE). More
Nature Medicine examines better alternatives to the current gold standard for early detection of prostate cancer, PSA, and assesses the creation of more effective and cost-efficient biomarker tests. More (pdf)
Canary Foundation Announces New Partnerships: Canary has engaged in six new partnerships in ovarian, prostate, and never-smoker lung cancer research. These partnerships will permit Canary to strengthen its research platforms. More
2008-2009 Clinical Proteomic Technologies for Cancer (CPTC) Annual Report Now Available: The CPTC Annual Report assesses the future of proteomic technologies and evaluates the adaptations necessary in the development of new novel cancer biomarkers. More (pdf)
Semantic Web highlights Canary Foundation's recent achievements in Bioinformatics: The article comments on the translational research informatics platform that is a result of Canary's partnership with GenoLogics, NCI's Early Detection Research Network, and NASA Jet Propulsion Laboratory. More
Canary Scientific Program Director, Sam Gambhir, M.D. Ph.D, has been awarded the 2009 Radiological Society of North America (RSNA) Outstanding Researcher Award. More
Copyright © 2010 Canary Foundation. All rights reserved.